Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01808937 · ClinicalTrials.gov registry record
Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
A clinical trial of Morphea and Scleroderma, Circumscribed, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT01808937: Recruiting study of Morphea and Scleroderma, Circumscribed, sponsored by University of Texas Southwestern Medical Center.
NCT01808937 is a study of Morphea and Scleroderma, Circumscribed that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01808937, a study of Morphea and Scleroderma, Circumscribed, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The Morphea in Adults and Children (MAC) cohort is the first registry for both children and adults with morphea (also known as localized scleroderma) in the country. The purpose of the registry is to learn more about morphea, specifically: * How morphea behaves over time * How frequently specific problems occur along with morphea (for example, arthritis) * Whether morphea has an autoimmune background
Conditions Studied
Interventions
- OTHER Morphea
Study Locations (1)
Texas
- UT Southwestern Medical Center - Department of Dermatology - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2007-05 |
| Est. Completion | 2028-01 |
What NCT01808937 shows while recruiting
NCT01808937 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 5 conditions, with Morphea appearing as the primary indexed condition, and to 1 intervention - of which Morphea is the first listed.
NCT01808937 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01808937 about?
NCT01808937 is a clinical study titled "Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository". The Morphea in Adults and Children (MAC) cohort is the first registry for both children and adults with morphea (also known as localized scleroderma) in the country. The purpose of the registry is to learn more about morphea, specifically: * How morphea behaves over time * How frequently specific p...
What is the current status of trial NCT01808937?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2007-05. Estimated completion is 2028-01.
What conditions does trial NCT01808937 study?
This clinical trial studies the following conditions: Morphea, Scleroderma, Circumscribed, Scleroderma, Localized, Frontal Linear Scleroderma en Coup de Sabre, Scleroderma, Linear.
What interventions are being tested in trial NCT01808937?
The interventions under investigation include: Morphea (OTHER).
Who is sponsoring clinical trial NCT01808937?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01808937 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Morphea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia